PLX5622 is a highly selective, brain-penetrant, orally active inhibitor of colony-stimulating factor 1 receptor (CSF1R), used in research to enable prolonged and specific elimination of microglial cells. It is primarily administered via a feed-free diet and exhibits favorable pharmacokinetic properties in various animal models.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1303420-67-8
1,14-TETRADECANEDIOIC-D24 ACID
research compound
Hexadecanedioic acid-d28
research compound
Heptanoic-d13 acid
research compound
NONANOIC-D17 ACID
research compound
Pexidartinib hydrochloride
pharmaceutical raw material
6-fluoro-N-[(5-fluoro-2-methoxy-3-pyridinyl)methyl]-5-[(5-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]pyridin-2-amine
NSMOZFXKTHCPTQ-UHFFFAOYSA-N
CC1=CC2=C(NC=C2CC3=C(N=C(C=C3)NCC4=C(N=CC(=C4)F)OC)F)N=C1